Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancerEzra E.W. Cohen, J.-P. Machiels, Lisa Licitra et al.|Annals of Oncology|2017Cited by 80
A systematic review of current and emerging approaches in the field of larynx preservationNerina Denaro, Marco Merlano, Jean Louis Lefèbvre et al.|Radiotherapy and Oncology|2013Cited by 49